Skip to content

Priming Exercise in Type 1 Diabetes

The Effects of Prior Exercise on Pulmonary Oxygen Uptake Kinetics and the Power-Duration Relationship in Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03285386
Acronym
PET1D
Enrollment
7
Registered
2017-09-18
Start date
2018-01-01
Completion date
2018-12-01
Last updated
2019-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

Critical power is an important threshold in exercise physiology, and is an important determinant of the ability to tolerate high-intensity exercise. The ability to tolerate such exercise is drastically impaired in certain chronic conditions, such as type 1 diabetes. Whilst the most important physiological factors that determine critical power have yet to be determined, previous work from our laboratory suggests that it is related to the speed of oxygen uptake at the onset of exercise. This study will look to utilise priming exercise as an intervention to improve the speed of these oxygen uptake kinetics, and thus critical power and exercise tolerance in individuals with type 1 diabetes. We hypothesize that oxygen uptake kinetics will be faster and critical power will be higher when exercise is performed with compared to without a prior bout of high-intensity priming exercise in a population of individuals with type 1 diabetes.

Detailed description

The ability to tolerate high-intensity exercise, or exercise tolerance, is a key factor that can influence clinical outcomes in a range of conditions. The critical power is an important physiological threshold that demarcates exercise intensities that can be sustained for prolonged periods (i.e. below critical power) from intensities that result in exhaustion in a relatively short period of time (i.e. 2-30 minutes, above critical power). Critical power is therefore a key determinant of exercise tolerance. The speed with which oxygen uptake rises at the onset of exercise (i.e. oxygen uptake kinetics) has been shown by work from our laboratory to be a key determinant of critical power. One intervention that can acutely improve the oxygen uptake kinetics is the performance of a prior bout of high-intensity exercise, known as priming exercise. Patients with type 1 diabetes have previously been shown to have impaired exercise tolerance compared to healthy controls. The performance of priming exercise therefore represents a potential intervention to acutely improve oxygen uptake kinetics, and therefore critical power and exercise tolerance, in type 1 diabetic individuals. The purpose of this study is therefore to assess the influence of priming exercise on oxygen uptake kinetics and critical power in a population of type 1 diabetic individuals.

Interventions

BEHAVIORALPriming exercise

All participants will perform a bout of high-intensity priming exercise for 6 minutes, 10 minutes prior to undertaking an exhaustive exercise test on four separate occasions.

All participants will perform 3 minutes of baseline cycling prior to undertaking an exhaustive exercise test on four separate occasions.

Sponsors

Liverpool Hope University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants will serve as their own controls. Participants will alternate between primed (experimental condition) and non-primed (control condition) in their visits.

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Suffering from Type 1 diabetes with a diagnosed disease duration of 2 - 20 years and no comorbidities.

Exclusion criteria

History of stroke, congestive heart failure, hypertension, or cardiopulmonary disease. Current smoking or have been smoking within the last 12 months Symptomatic autonomic or distal neuropathy HbA1c \> 64 mmol/mol Hypoglycaemia unawareness in the last 6 months Taking any medications other than insulin.

Design outcomes

Primary

MeasureTime frameDescription
Critical power3-9 weeksThe power asymptote of the hyperbolic relationship between power and the tolerable duration of exercise.
Phase II time constant of pulmonary oxygen uptake kinetics3-9 weeksTime taken for oxygen uptake to attain 63% of its asymptotic amplitude.
Time constant for muscle deoxygenation kinetics (assessed by near-infrared spectroscopy)3-9 weeksTime taken for muscle deoxyhaemoglobin to attain 63% of its asymptotic amplitude.

Secondary

MeasureTime frameDescription
W'3-9 weeksCurvature constant of the power-duration relationship. Finite work capacity available above critical power.
Time constant for heart rate kinetics3-9 weeksTime taken for heart rate to attain 63% of its asymptotic amplitude.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026